메뉴 건너뛰기
American Journal of Kidney Diseases
Volumn 52, Issue 5, 2008, Pages 1022-1023
Progression of Calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study
Author keywords

[No Author keywords available]
Indexed keywords

ATORVASTATIN; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE BINDING AGENT; SEVELAMER;
EID: 54149098989     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.07.043     Document Type: Letter
Times cited : (8)
References (9)
  • 1
    • 43849109612 scopus 로고    scopus 로고
    • Calcification in CKD: No closer to the cure
    • Kestenbaum B. Calcification in CKD: No closer to the cure. Am J Kidney Dis 51 (2008) 877-879
    • (2008) Am J Kidney Dis , vol.51 , pp. 877-879
    • Kestenbaum, B.1
  • 2
    • 43849094954 scopus 로고    scopus 로고
    • A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study
    • Qunibi W., Moustafa M., Muenz L.R., et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. Am J Kidney Dis 51 (2008) 952-965
    • (2008) Am J Kidney Dis , vol.51 , pp. 952-965
    • Qunibi, W.1    Moustafa, M.2    Muenz, L.R.3
  • 3
    • 0036310682 scopus 로고    scopus 로고
    • Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
    • Chertow G.M., Burke S.K., and Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62 (2002) 245-252
    • (2002) Kidney Int , vol.62 , pp. 245-252
    • Chertow, G.M.1    Burke, S.K.2    Raggi, P.3
  • 4
    • 31644446801 scopus 로고    scopus 로고
    • Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
    • Block G.A., Spiegel D.M., Ehrlich J., et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68 (2005) 1815-1824
    • (2005) Kidney Int , vol.68 , pp. 1815-1824
    • Block, G.A.1    Spiegel, D.M.2    Ehrlich, J.3
  • 5
    • 35848951189 scopus 로고    scopus 로고
    • The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer
    • Russo D., Miranda I., Ruocco C., et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 72 (2007) 1255-1261
    • (2007) Kidney Int , vol.72 , pp. 1255-1261
    • Russo, D.1    Miranda, I.2    Ruocco, C.3
  • 6
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
    • (2005) N Engl J Med , vol.353 , pp. 238-248
    • Wanner, C.1    Krane, V.2    Marz, W.3
  • 7
    • 39449117385 scopus 로고    scopus 로고
    • Comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: A secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data
    • St Peter W.L., Liu J., Weinhandl E., et al. Comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: A secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data. Am J Kidney Dis 51 (2008) 445-454
    • (2008) Am J Kidney Dis , vol.51 , pp. 445-454
    • St Peter, W.L.1    Liu, J.2    Weinhandl, E.3
  • 8
    • 39449100246 scopus 로고    scopus 로고
    • Phosphate binder choice in dialysis patients: A call for evidence-based rather than marketing-based clinical practice
    • Winkelmayer W.C., and Tonelli M. Phosphate binder choice in dialysis patients: A call for evidence-based rather than marketing-based clinical practice. Am J Kidney Dis 51 (2008) 362-365
    • (2008) Am J Kidney Dis , vol.51 , pp. 362-365
    • Winkelmayer, W.C.1    Tonelli, M.2
  • 9
    • 36049029061 scopus 로고    scopus 로고
    • Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
    • Tonelli M., Wiebe N., Culleton B., et al. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients. Nephrol Dial Transplant 22 (2007) 2856-2866
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 2856-2866
    • Tonelli, M.1    Wiebe, N.2    Culleton, B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.